Dr Paul Mattick, Head of Sales & Private Investor Relations
The next six weeks are critical for those looking to invest in Enterprise Investment Schemes (EIS) – with capital preservation EIS funds no longer available, investors and Financial Advisers are evaluating capital growth EIS funds. The Patient Capital Review heralded a new era for EIS, after which tax-efficient investment must be directed towards high-growth technology companies, which have the potential to grow UK gross domestic product. These changes may initially appear to complicate EIS for financial advisers, but there are a number of reasons that EIS remains a vital tool in the financial adviser’s tool kit.
Dr Paul Mattick, Director of Mercia EIS Funds, talks to GB Investments Magazine to explain why IFAs should be considering EIS for their clients. You can read the full article here.